Alkem Laboratories, a top-seller of antibiotics, is focusing on the chronic therapy segments and is investing heavily in biosimilars and contract development and manufacturing services, its managing director, Sandeep Singh, told ET. The Mumbai-based drug maker, which entered the US generics market o…

Alkem Labs to grow chronic therapies, biosimilars to drive future growth: MD

The Mumbai-based drug maker, which entered the US generics market over a decade ago, is also scaling back its investments in oral solids in the face of competition and price erosion.

Alkem Labs to grow chronic therapies to drive future growth: MD

Based on the OI percentage, 60 stocks were on the short-covering list. These included Alkem Laboratories, IndusInd Bank, United Breweries, Dr Lal PathLabs and Aarti Industries.

Trade setup for Thursday: Top 15 things to know before the opening bell

Motilal Oswal recommended Neutral rating on Alkem Laboratories with a target price of Rs 3470 in its research report dated May 20, 2023.

Neutral Alkem Laboratories; target of Rs 3470: Motilal Oswal

Based on the OI percentage, 50 stocks, including Alkem Laboratories, Intellect Design Arena, InterGlobe Aviation, L&T Finance Holdings and Balrampur Chini Mills saw long unwinding.

Trade setup for Wednesday: Top 15 things to know before the opening bell

Alkem Laboratories posted revenue from operations for the fiscal fourth quarter at Rs 2902.60 crore, up 16.9 per cent from Rs 2483.86 crore in the fourth quarter of FY22.

Alkem Laboratories Q4FY23 Results: Profit tumbles 34% to Rs 71 crore, revenue up 16.9% on-year | The Financial Express

Based on the OI percentage, 66 stocks, including Balrampur Chini Mills, REC, Alkem Laboratories, Ashok Leyland, and Jindal Steel & Power saw a short build-up.

Trade setup for today: Top 15 things to know before the opening bell

​​In the pharmaceutical sector, fewer incidents of regulatory breaches and attractive valuations drove fund managers to add stocks such as Alkem Laboratories, Ajanta Pharma, and Dr Reddys Laboratories.

Beaten-down realty, pharma top mutual fund buys in April

Based on the OI percentage, 77 stocks, including Alkem Laboratories, Vedanta, GNFC, Bharat Forge, and Balrampur Chini Mills saw a short build-up.

Based on the OI percentage, 79 stocks including Hindustan Aeronautics, Vedanta, Voltas, Alkem Laboratories, and Vodafone Idea, saw a short build-up.

Trade setup for Friday: Top 15 things to know before the opening bell

Stocks to watch out for today: Bharat Forge, Adani Transmission, Sanofi India, Alkem Laboratories, Infosys, RVNL and more

Stocks in news: Adani Transmission, Infosys, Rail Vikas Nigam, Bharat Forge and more

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Alkem Laboratories Limited is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.